Kcnab2 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Kcnab2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
KCNAB2 encodes the beta2 subunit of voltage-gated potassium channels. It interacts with the pore-forming alpha subunits to modulate channel function and neuronal excitability.
| Attribute | Value |
|---|---|
| Symbol | KCNAB2 |
| Full Name | Potassium Voltage-Gated Channel Subfamily A Member Beta 2 |
| Chromosomal Location | 1p36.33 |
| NCBI Gene ID | 7882 |
| OMIM ID | 601507 |
| Ensembl ID | ENSG00000069702 |
| UniProt ID | P56381 |
KCNAB2 encodes Kvβ2.1, the most widely expressed beta subunit in the brain. Unlike Kvβ1.1, Kvβ2.1 does not induce N-type inactivation but instead stabilizes channel expression at the plasma membrane and modulates gating kinetics 1. Kvβ2.1 can form heteromers with Kvβ1.x subunits, creating diverse channel populations with distinct properties.
In neurons, Kvβ2.1 associates with Kv1.x channels (particularly Kv1.2) to regulate action potential repolarization, spike frequency adaptation, and synaptic integration. The beta subunits can undergo oxidative modification, leading to altered channel function during oxidative stress conditions common in neurodegenerative diseases 2.
KCNAB2 has been studied in the context of Alzheimer's disease (AD). Amyloid-beta peptide accumulation leads to oxidative stress in neurons, which can modify Kvβ2.1 and alter Kv1.x channel function. This contributes to neuronal dysfunction and synaptic loss in AD 3. Some studies have found altered Kvβ2.1 expression in AD brain tissue.
Kv1.x channels are critical for maintaining proper neuronal excitability. Dysregulation of KCNAB2 can contribute to hyperexcitability and seizure disorders. Kvβ2.1 knockout mice show increased susceptibility to seizures 4.
Gene association studies have identified KCNAB2 as a potential susceptibility gene for schizophrenia. Altered potassium channel function may affect neuronal circuitry underlying cognitive deficits in this disorder 5.
KCNAB2 is highly expressed throughout the brain, with particular enrichment in the hippocampus, cerebral cortex, thalamus, and basal ganglia. It is expressed in both excitatory pyramidal neurons and inhibitory interneurons. Peripheral expression includes heart, skeletal muscle, and pancreas.
Targeting Kvβ2.1 function offers potential therapeutic strategies:
Kcnab2 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Kcnab2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.